Fundraising Fox
Paul Berns
InvestorUnicorn founderChairman and Chief Executive Officer at Neumora Therapeutics · Managing Director at ARCH Venture Partners
Wisconsin
Writes $50K – $150M checks · typically $25M
FoundedNeumora Therapeutics$2.6B
Find your path to Paul
Sign up to see every warm intro you have to Paul
- Paths you didn't know you had: your email and LinkedIn already hold routes to Paul. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Paul Berns is a pharma operator who helped architect Humira, led Anacor (sold to Pfizer for over $5 billion), co-founded and runs Neumora, with unusually direct large-scale commercialization experience.
Likely email· guessed from name + firm domain, not firm-published
- p•••@archventure.comreveal100% confident
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices
Chairman and Chief Executive Officer at Neumora Therapeutics
Intro paths
In turn, Paul can intro founders to Neumora Therapeutics's investors below.
Neumora Therapeutics's investors · 19
Co-founders at Neumora Therapeutics
Deals · 1
Ollin Biosciences, Inc.Board seat
via ARCH Venture Partners · filed Jun 2026 · $330M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Areteia TherapeuticsBlackThorn TherapeuticsElephasEpirium BioHappy HealthHI-BioKaizen Brain CenterKardiganMatter NeuroscienceMetseraTenvie
Sources: SEC Form D filings · curated public sources.
Colleagues at ARCH Venture Partners
Network1
Investors connected to Paul in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Paul Berns?
- Paul Berns is a pharma operator who helped architect Humira, led Anacor (sold to Pfizer for over $5 billion), co-founded and runs Neumora, with unusually direct large-scale commercialization experience.
- Where does Paul Berns work?
- Paul Berns is Chairman and Chief Executive Officer of Neumora Therapeutics and Managing Director at ARCH Venture Partners.
- What does Paul Berns invest in?
- Paul Berns invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
- What check size does Paul Berns write?
- Paul Berns typically writes checks of $50K – $150M.
- What companies did Paul Berns found?
- Paul Berns founded Neumora Therapeutics.
- What boards does Paul Berns sit on?
- Paul Berns holds tracked board seats at Areteia Therapeutics, Elephas Biosciences, Metsera, Mirador Therapeutics, Ollin Biosciences, Inc..
- What companies has Paul Berns invested in?
- Investments tracked here include Areteia Therapeutics, BlackThorn Therapeutics, Elephas, Epirium Bio, Happy Health, HI-Bio, Kaizen Brain Center, Kardigan, Matter Neuroscience, Metsera, Ollin Biosciences, Inc., Tenvie.
Founder mafias
ARCH Venture Partners mafia19
Also came through, then founded or led a company.
Unity Biotechnology mafia6
Also came through, then founded or led a company.
Metsera mafia3
Also came through, then founded or led a company.
Mirador Therapeutics mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — ARCH Venture Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights